Efficacy of different doses of aspirin in decreasing blood levels of inflammatory markers in patients with cardiovascular metabolic syndrome. [electronic resource]
Producer: 20100316Description: 1505-10 p. digitalISSN:- 2042-7158
- Adult
- Aged
- Anti-Inflammatory Agents -- administration & dosage
- Aspirin -- administration & dosage
- Biomarkers -- blood
- C-Reactive Protein -- metabolism
- Cardiovascular Diseases -- prevention & control
- Dose-Response Relationship, Drug
- Double-Blind Method
- Female
- Humans
- Inflammation -- drug therapy
- Inflammation Mediators -- blood
- Interleukin-6 -- blood
- Male
- Metabolic Syndrome -- blood
- Middle Aged
- Platelet Aggregation Inhibitors -- administration & dosage
- Prospective Studies
- Thromboxane B2 -- blood
- Tumor Necrosis Factor-alpha -- blood
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.